Press "Enter" to skip to content

Cadila Healthcare Q3 net dips 34% to Rs 281.6 cr


Drug firm Cadila Healthcare today reported 34.58 per cent dip in consolidated net profit to Rs 281.6 crore for the third quarter ended December 31, 2016-17.

It had posted net profit of Rs 430.5 crore for the October -December period of 2015-16, Cadila said in a filing to BSE.

The company’s consolidated total income from operations also declined to Rs 2,363.8 crore for the quarter under review, as against Rs 2,408.9 crore in the year-ago period.

Cadila Healthcare stock was trading 8.81 per cent down at Rs 342.50 on BSE.

(This article has not been edited by DNA’s editorial team and is auto-generated from an agency feed.)